Clinical Trials Browser

Phase 1/2 × Carcinoma, Hepatocellular × napabucasin × Clear all

NCT02279719 2023-11-15

A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma

Phase 1/2 Completed

97 enrolled 17 charts

Gastrointestinal

Carcinoma, Hepatocellular